Observational studyClinical and translational science2020

Early Adalimumab and Anti-Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients.

Xiaoliang Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.